Abstract
A family of six cardiovascular hormones--atrial natriuretic peptide, brain natriuretic peptide, C-natriuretic peptide, long acting natriuretic peptide, vessel dilator and kaliuretic peptide--was investigated for the ability to decrease the number of human angiosarcoma cells. Within 24 h, vessel dilator, long acting natriuretic peptide, kaliuretic peptide, atrial natriuretic peptide and their intracellular mediator cyclic GMP decreased the number of angiosarcoma cells by 61, 30, 29, 36 and 32%, respectively, and DNA synthesis by 68-85%. Brain natriuretic peptide and C-natriuretic peptide had no effect(s). The natriuretic peptide receptor C was present. Four cardiovascular hormones decrease the number of angiosarcoma cells within 24 h via inhibition of DNA synthesis mediated in part by cyclic GMP.
References
May 1, 1992·The Journal of Clinical Investigation·M E GunningM L Zeidel
Sep 1, 1989·Circulation·C J WintersD L Vesely
Dec 1, 1989·Proceedings of the Society for Experimental Biology and Medicine·D L VeselyM Epstein
Nov 13, 1987·Biochemical and Biophysical Research Communications·D L VeselyD A Baeyens
Oct 29, 1982·Science·H G Gratzner
Feb 1, 1995·Clinical and Experimental Pharmacology & Physiology·M L Zeidel
Jan 1, 1994·Peptides·W R GowerD L Vesely
Sep 1, 1994·Circulation·D L VeselyD D Schocken
Jan 1, 1996·Peptides·C S BarrA D Struthers
Feb 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·J L ArbiserJ Folkman
Jul 22, 1998·Scandinavian Journal of Clinical and Laboratory Investigation·E F Macaulay HunterP J Lowry
Aug 26, 1998·Circulation·D L VeselyD D Schocken
Dec 9, 1998·The American Journal of Physiology·K S MurthyG M Makhlouf
May 7, 1999·Histopathology·A V DonsbeckR Loire
Jul 8, 2000·Kidney International·M FranzW H Hörl
Apr 25, 2001·Kidney International·M FranzW H Hörl
Jul 10, 2002·IUBMB Life·David L Vesely
Jul 5, 2003·American Journal of Physiology. Renal Physiology·David L Vesely
Jul 31, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G CserniUNKNOWN European Working Group for Breast Screening Pathology
Aug 23, 2003·Journal of the American College of Cardiology·John G LainchburyA Mark Richards
Nov 26, 2003·European Journal of Clinical Investigation·B A VeselyD L Vesely
Feb 21, 2004·CA: a Cancer Journal for Clinicians·Ahmedin JemalUNKNOWN American Cancer Society
Oct 12, 2004·European Journal of Clinical Investigation·D L VeselyW R Gower
Jan 11, 2005·European Journal of Clinical Investigation·B A VeselyD L Vesely
May 17, 2005·Cancer Letters·Brian A VeselyDavid L Vesely
Jun 14, 2005·European Journal of Clinical Investigation·B A VeselyD L Vesely
Citations
Mar 28, 2013·Endocrine-related Cancer·David L Vesely
May 29, 2007·Endocrine·Ehrentraud J EichelbaumDavid L Vesely
Nov 16, 2007·The American Journal of the Medical Sciences·Brian A VeselyDavid L Vesely
Oct 13, 2006·European Journal of Clinical Investigation·B A VeselyD L Vesely
Jan 1, 2011·Cancers·David L Vesely
Aug 28, 2009·American Journal of Physiology. Cell Physiology·Abdel A Alli, William R Gower
Jul 9, 2021·Biomedical Journal·Mengjiao XuGeng Yang